Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro study
Sabrina Kuoni(University of Zurich), Ana Paula Simões‐Wüst(The Swiss Private Equity & Corporate Finance Association), Roger Lehmann(University of Zurich), Nicole Ochsenbein‐Kölble(University of Zurich), R. Steiner(University Hospital Zurich), Lanja Saleh(University Hospital Zurich)
Cited by 15
Related Papers
DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans
|Journal of Clinical Investigation|2019|131
Impaired ABCA1/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration
|eLife|2019|100
Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease
|Kidney International|2014|94
Elucidating the chemical structure of native 1-deoxysphingosine
|Journal of Lipid Research|2016|57